advanced breast cancer
Meta-analysis of all clinical data was conducted to compare toremifene 40-60       mg/day (TOR) with tamoxifen 20-40 mg/day (TAM) in postmenopausal women with       estrogen receptor (ER) positive or ER unknown advanced breast cancer and assess       factors predicting treatment outcome.
Meta-analysis of all clinical data was conducted to compare toremifene 40-60       mg/day (TOR) with tamoxifen 20-40 mg/day (TAM) in postmenopausal women with       estrogen receptor (ER) positive or ER unknown  @SUBJECT$  @OBJECT$  @PREDICAT$  and assess       factors predicting treatment outcome.